May 17, 2017
Wilson Therapeutics AB (publ) Interim Report January 1 – March 31, 2017
Media
May 16, 2017
Nordic Nanovector ASA: Invitation to First Quarter 2017 Results Presentation and Webcast
May 16, 2017
Altimmune Promotes Dr. Sybil Tasker to Chief Medical Officer
May 16, 2017
Strongbridge Biopharma plc Provides Corporate Update and Reports First Quarter 2017 Financial Results
May 11, 2017
Interim report January – March 2017
May 10, 2017
Onxeo announces allowance of U.S. patent for Livatag® in hepatocellular carcinoma
May 10, 2017
Wilson Therapeutics to host conference call to provide first quarter 2017 business update
May 10, 2017
Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study
May 08, 2017
Targovax ASA: Capital Markets Updates in Oslo on Thursday 8 June and in London on Monday 26 June 2017
May 08, 2017
Nexstim Plc Terminates Market Making Agreement with Pareto Securities AB in Nasdaq First North Sweden
